The CDAHFD‐0.1 group with insufficient methionine content increased insulin sensitivity and induced severe ‘nonobese’ NASH characterized by inflammation, fibrosis, and the development of proliferative lesions in the liver. Here, INS is linked to metabolic dysfunction-associated steatohepatitis.